Compare NL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NL | SLP |
|---|---|---|
| Founded | 1891 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.9M | 322.4M |
| IPO Year | N/A | 1997 |
| Metric | NL | SLP |
|---|---|---|
| Price | $5.68 | $17.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $27.25 |
| AVG Volume (30 Days) | 36.8K | ★ 247.1K |
| Earning Date | 11-06-2025 | 01-08-2026 |
| Dividend Yield | ★ 10.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $159,004,000.00 | $79,179,000.00 |
| Revenue This Year | $15.75 | $2.42 |
| Revenue Next Year | $2.44 | $7.05 |
| P/E Ratio | $27.97 | ★ N/A |
| Revenue Growth | 5.52 | ★ 13.09 |
| 52 Week Low | $5.04 | $12.39 |
| 52 Week High | $9.27 | $37.67 |
| Indicator | NL | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 42.68 |
| Support Level | $5.34 | $17.73 |
| Resistance Level | $5.72 | $19.78 |
| Average True Range (ATR) | 0.23 | 0.75 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 68.42 | 5.85 |
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.